Literature DB >> 11207479

Increased blood-brain barrier permeability of morphine in a patient with severe brain lesions as determined by microdialysis.

R Bouw1, P Ederoth, J Lundberg, U Ungerstedt, C H Nordström, M Hammarlund-Udenaes.   

Abstract

Intracerebral microdialysis was utilised to obtain information regarding how morphine is transported across the blood-brain barrier (BBB). In a patient with a severe brain injury, we measured simultaneously unbound extracellular fluid (ECF) concentrations of morphine in human brain and in subcutaneous fat tissue, which were compared to morphine levels in arterial blood. This report shows an increase in morphine levels near the trauma site in the brain compared to uninjured brain tissue. The half-life of morphine in uninjured and injured brain tissue of 178 min and 169 min, respectively, were comparable but were longer than in blood (64 min) and adipose tissue (63 min). This indicates that morphine is retained in brain tissue for a longer time than what could be expected from the blood concentration-time profile. These results show the potential of the microdialysis technique in providing new information regarding the pharmacokinetics of drug in the human brain close to the trauma site and in macroscopically intact tissue.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11207479     DOI: 10.1034/j.1399-6576.2001.045003390.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  15 in total

Review 1.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

2.  Brain microdialysis study of meropenem in two patients with acute brain injury.

Authors:  Claire Dahyot-Fizelier; Ivan Timofeev; Sandrine Marchand; Peter Hutchinson; Bertrand Debaene; David Menon; Olivier Mimoz; Arun Gupta; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

3.  Levels of vancomycin in the cerebral interstitial fluid after severe head injury.

Authors:  Anselmo Caricato; Mariano Pennisi; Aldo Mancino; Gianluca Vigna; Claudio Sandroni; Andrea Arcangeli; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

4.  Computational framework for predictive PBPK-PD-Tox simulations of opioids and antidotes.

Authors:  Carrie German; Minu Pilvankar; Andrzej Przekwas
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-08-08       Impact factor: 2.745

Review 5.  Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling.

Authors:  Elizabeth C M de Lange; Paulien G M Ravenstijn; Dorien Groenendaal; Tamara J van Steeg
Journal:  AAPS J       Date:  2005-10-07       Impact factor: 4.009

6.  Effects of μ-opioid receptor modulation on the hippocampal network activity of sharp wave and ripples.

Authors:  Panagiotis Giannopoulos; Costas Papatheodoropoulos
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

Review 7.  Understanding the brain uptake and permeability of small molecules through the BBB: A technical overview.

Authors:  Ekram Ahmed Chowdhury; Behnam Noorani; Faleh Alqahtani; Aditya Bhalerao; Snehal Raut; Farzane Sivandzade; Luca Cucullo
Journal:  J Cereb Blood Flow Metab       Date:  2021-01-14       Impact factor: 6.200

8.  Unbound Brain-to-Plasma Partition Coefficient, Kp,uu,brain-a Game Changing Parameter for CNS Drug Discovery and Development.

Authors:  Irena Loryan; Andreas Reichel; Bo Feng; Christoffer Bundgaard; Christopher Shaffer; Cory Kalvass; Dallas Bednarczyk; Denise Morrison; Dominique Lesuisse; Edmund Hoppe; Georg C Terstappen; Holger Fischer; Li Di; Nicola Colclough; Scott Summerfield; Stephen T Buckley; Tristan S Maurer; Markus Fridén
Journal:  Pharm Res       Date:  2022-04-11       Impact factor: 4.580

Review 9.  Utility of CSF in translational neuroscience.

Authors:  Elizabeth C M de Lange
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-02-12       Impact factor: 2.745

Review 10.  Cerebral microdialysis in clinical studies of drugs: pharmacokinetic applications.

Authors:  Richard J Shannon; Keri L H Carpenter; Mathew R Guilfoyle; Adel Helmy; Peter J Hutchinson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-03-07       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.